CIK 0001603454 · Non-accelerated filer<br>Smaller reporting company
Celcuity Inc.
Sign in to watch- Ticker
- CELC
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 763-392-0767
- Business address
- 16305 36TH AVENUE N, SUITE 100, MINNEAPOLIS, MN, 55446
- Former names
- Celcuity LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-17 | Dalvey David Director | Returned to the company · Stock Option (right to buy) | −8,200 | 0 | ||
| 2022-05-17 | Dalvey David Director | Grant or award · Stock Option (right to buy) | +8,200 | 8,200 | ||
| 2022-05-17 | Dalvey David Director | Returned to the company · Stock Option (right to buy) | −3,201 | 0 | ||
| 2022-05-17 | Dalvey David Director | Grant or award · Stock Option (right to buy) | +3,201 | 3,201 | ||
| 2022-05-17 | Dalvey David Director | Returned to the company · Stock Option (right to buy) | −5,054 | 0 | ||
| 2022-05-17 | Dalvey David Director | Grant or award · Stock Option (right to buy) | +5,054 | 5,054 | ||
| 2022-05-17 | Dalvey David Director | Returned to the company · Stock Option (right to buy) | −2,310 | 0 | ||
| 2022-05-17 | Dalvey David Director | Grant or award · Stock Option (right to buy) | +2,310 | 2,310 | ||
| 2022-05-17 | Dalvey David Director | Grant or award · Stock Option (right to buy) | +24,449 | 24,449 | ||
| 2022-05-17 | Buller Richard E Director | Grant or award | +3,273 | 11,798 | ||
| 2022-05-17 | Buller Richard E Director | Returned to the company · Stock Option (right to buy) | −4,555 | 0 | ||
| 2022-05-17 | Buller Richard E Director | Grant or award · Stock Option (right to buy) | +4,555 | 4,555 | ||
| 2022-05-17 | Buller Richard E Director | Returned to the company · Stock Option (right to buy) | −2,310 | 0 | ||
| 2022-05-17 | Buller Richard E Director | Grant or award · Stock Option (right to buy) | +2,310 | 2,310 | ||
| 2022-05-17 | Buller Richard E Director | Grant or award · Stock Option (right to buy) | +19,558 | 19,558 | ||
| 2022-05-17 | Hahne Vicky Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −3,000 | 0 | ||
| 2022-05-17 | Hahne Vicky Chief Financial Officer | Grant or award · Stock Option (right to buy) | +3,000 | 3,000 | ||
| 2022-05-17 | Hahne Vicky Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −932 | 0 | ||
| 2022-05-17 | Hahne Vicky Chief Financial Officer | Grant or award · Stock Option (right to buy) | +932 | 932 | ||
| 2022-05-17 | Hahne Vicky Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −3,000 | 0 |
Page 12 of 19 · 365 trades